Moreover, genes involved in the pathway crosstalk may play core roles in the relapse of T-ALL, such as BCL2, which was a potential therapeutic strategy for T-ALL (Figure 5A).45 The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.